We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bristol-Myers Squibb (BMS) and AstraZeneca announced that they are collaborating to develop and commercialize two experimental drugs for Type 2 diabetes.
Elite Pharmaceuticals is teaming up with VGS Pharma to create a research and development company geared toward manufacturing specialty generic drugs, the company announced.
Plaintiffs are asking the Supreme Court to review the dismissal of a case to determine the legality of reverse payment agreements, where brand drugmakers pay generic rivals to keep their low-cost versions of prescription products off the market.
CVS’s attempt to take over Caremark got a boost as the pharmaceutical services company announced it is rejecting a $26 billion bid from Express Scripts, saying it was not in the shareholders’ best interests.
Biotech company Synosis will acquire five drug candidates that target the central nervous system as part of a new partnership with Roche, Synosis announced.
German company Altana has completed the sale of its pharmaceutical business to Danish drugmaker Nycomed for approximately $6 billion, Altana announced.